Discover 2,163 paid clinical trials in Carlsbad, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,163
Rituxan and Abraxane for the Treatment of Patients With Inoperable Stage III and IV Malignant Melanoma
for
Malignant Melanoma of Skin Stage III, Metastatic Melanoma
Location: Encinitas CA
Sponsor: California Cancer Assocaties for Research & Excellence
Sex: All
Age: 18+
Code: NCT02142335
Phase 2, Recruiting
New
An Open-Label, Two-Arm Pilot Study of the Tolerability, Consumer Acceptability, and Exploratory Well-Being Outcomes of a Multi-Ingredient Protein Formula in Two Flavors in Healthy Adults
for
Healthy
Location: Carlsbad CA
Sponsor: Qualia Life Sciences
Sex: All
Age: 21 - 65
Code: NCT07827014
Recruiting
New
Impact of Two Iron Formulations on Iron Biomarkers and Quality of Life
for
Iron Deficiencies
Location: Carlsbad CA
Sponsor: Qualia Life Sciences
Sex: All
Age: 18+
Code: NCT07156526
Recruiting
Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)
for
Diabetic Foot Infection
Location: Vista CA, Corona CA
Sponsor: MicuRx
Sex: All
Age: 18+
Code: NCT05369052
Phase 3, Recruiting
Establishing Normal Cognitive Test Scores for Adults Using a Voice-Enabled Digital Testing Platform Across the Lifespan
Sponsor: The Neurology Center of Southern California
Sex: All
Age: 18 - 70+
Code: NCT07763392
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
for
Chronic Lymphocytic Leukemia
Location: Oceanside CA, Vista CA, Fountain Valley CA,
Sponsor: East Valley Hematology and Oncology Medical Group
Sex: All
Age: 18+
Code: NCT00131313
Recruiting
Active & Responsive
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
for
Major Depressive Disorder
Location: Irvine CA, Los Angeles CA, Walnut Creek CA, Orem UT,
Sponsor: Syndeio Biosciences, Inc
Sex: All
Age: 18 - 64
Code: NCT06547489
Phase 2, Recruiting
Active & Responsive
A Study of YL201 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: La Jolla CA, Fair Oaks CA, Santa Fe NM, Lone Tree CO,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All
Age: 18+
Code: NCT05434234
Phase 1, Phase 2, Recruiting
Featured
A Study to Assess How Intravenous and Subcutaneous Administrations of Risankizumab Moves Through the Body of Healthy Adult Participants
for
Healthy Volunteer
Location: Anaheim CA, Miami FL
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT07466550
Phase 1, Recruiting
A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
for
IgA Nephropathy
Location: Chula Vista CA, Arvada CO, Denver CO, Houston TX,
Sponsor: Jade Biosciences, Inc.
Sex: All
Age: 18 - 60
Code: NCT07541287
Phase 2, Recruiting
Featured
A Study of ABBV-295 Subcutaneous Injections to Assess Adverse Events and Pharmacokinetics in Adult Participants With Obesity
for
Obesity
Location: Anaheim CA, Grayslake IL
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT07291232
Phase 1, Recruiting
Featured
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
for
Non-Small Cell Lung Cancer,
Location: Irvine CA, Duarte CA, Los Angeles CA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT05005403
Phase 1, Recruiting
Featured
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
for
Chronic Lymphocytic Leukemia (CLL)
Location: La Jolla CA, Duluth MN, Hattiesburg MS, Atlanta GA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT04895436
Phase 2, Recruiting
FeaturedActive & Responsive
A Study to Assess the Safety, Tolerability and How Single Ascending Doses of ABBV-859 Moves Through the Body of Healthy Adult Participants
for
Healthy Volunteer
Location: Anaheim CA, Grayslake IL
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT07736638
Phase 1, Recruiting
FeaturedActive & Responsive
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
for
Major Depressive Disorder
Location: Temecula CA, Lemon Grove CA, Anaheim CA, Long Beach CA,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT07276997
Phase 2, Recruiting
FeaturedActive & Responsive
A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume
for
Mid Face Volume Deficit
Location: San Diego CA, Glendale AZ, Portland OR, Austin TX,
Sponsor: AbbVie
Sex: All
Age: 22+
Code: NCT06734351
Phase 3, Recruiting
FeaturedActive & Responsive
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
for
Migraine
Location: La Jolla CA, Austin TX, Mequon WI, Birmingham AL,
Sponsor: AbbVie
Sex: All
Age: 18 - 70
Code: NCT06602479
Phase 2, Recruiting
FeaturedActive & Responsive
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
for
Hypothyroidism
Location: Encinitas CA, La Jolla CA, Bonita CA, Newport Beach CA,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT06345339
Phase 2, Phase 3, Recruiting
FeaturedActive & Responsive
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
for
Bipolar I Disorder, Bipolar II Disorder
Location: Oceanside CA, Orange CA, Anaheim CA, Garden Grove CA,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT06696755
Phase 2, Recruiting
Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration